A patient has a nonspecific solid‑appearing lesion in the left hepatic lobe and an MRI has been ordered; should the patient also be referred to gastroenterology (GI) for further evaluation?

Wait for MRI Results Before GI Referral

You should wait for the MRI results before referring to gastroenterology, as the MRI will establish a definitive diagnosis in 95% of cases and eliminate the need for GI referral in the majority of patients. 1

Rationale for This Approach

The ACR Appropriateness Criteria (2020) clearly demonstrate that MRI with and without IV contrast can establish a definitive diagnosis in 95% of liver lesions, significantly outperforming CT and requiring further imaging in only 1.5% of cases 1. This high diagnostic yield means that most patients will have their lesion fully characterized without specialist intervention.

MRI Diagnostic Performance

The imaging characteristics will guide your next steps:

• Gadoxetate-enhanced MRI achieves 95-99% accuracy for hemangioma, 88-99% for focal nodular hyperplasia (FNH), and 97% for hepatocellular carcinoma 1
• Diffusion-weighted imaging combined with hepatobiliary phase imaging correctly classifies lesions as benign or malignant in 91% of cases 1
• For hemangioma specifically: 93% sensitivity, 99% specificity, 98% accuracy 1

When to Refer to GI After MRI

Refer to GI if MRI shows:

• Malignant features or indeterminate findings requiring biopsy guidance and management planning 1
• Hepatocellular adenoma (needs specialist management due to bleeding/malignant transformation risk) 1
• Any lesion requiring tissue diagnosis when imaging remains inconclusive 1
• Findings suggesting underlying chronic liver disease not previously diagnosed 1

Do NOT refer to GI if MRI confirms:

• Hemangioma - benign, requires only reassurance 2, 3
• Simple cyst - no follow-up needed 1
• Focal nodular hyperplasia - benign, typically requires no intervention 1, 3

Critical Pitfall to Avoid

Do not order a biopsy before advanced imaging. The ACR guidelines explicitly state that indeterminate liver lesions detected on ultrasound should undergo diagnostic CT or MRI prior to biopsy to avoid unnecessary biopsies of benign lesions like hemangiomas or FNH 1. Image-guided biopsies carry 9-12% bleeding risk, particularly with hypervascular lesions 1.

Practical Algorithm

1. Ensure MRI protocol includes: contrast-enhanced sequences with gadolinium (preferably gadoxetate), diffusion-weighted imaging, and hepatobiliary phase 1

2. Review MRI results:

   • If benign diagnosis confirmed → reassure patient, no GI referral needed
   • If malignant or indeterminate → refer to GI for biopsy consideration and management
   • If adenoma suspected → refer to GI/hepatology for surveillance planning

3. Only 1.5% of patients will need additional workup after proper MRI 1

The multidisciplinary approach involving GI is appropriate after imaging characterization, not before 2, 4. In the rare scenario where MRI remains indeterminate despite optimal technique, then GI referral for potential biopsy guidance becomes necessary 1.